10-4-11: ”Wunderlich Securities Maintains HOLD on Heartware [PT=$80]”
By Jonathan Chen, Benzinga Staff Writer
http://www.benzinga.com/analyst-ratings/analyst-color/11/10/1963665/wunderlich-securities-maintains-hold-on-heartware
Wunderlich Securities is out with a research report on Heartware (NASDAQ: HTWR) and is maintaining its Hold rating and $80 price target on shares.
In a note to clients, Wunderlich writes,
"Heartware (HTWR) provided an update of its ADVANCE bridge-to-transplant clinical trial Sunday during the EACTS Annual Meeting in Lisbon, Portugal. The update included data from the 140 patients in the ADVANCE trial and an additional 101 patients with at least 6 months of followup post implant from the Continued Access Protocol (CAP) allotments. The update was consisent with Heartware's June clinical update, showing reduced rates of thrombus requiring a pump exchange. The combined data suggest a thrombus rate under 5% is more likely for HVAD, which we believe will ease the concerns that arose back in April at the ISHLT meeting. We maintain our Hold rating and $80 target."
= = = = = = = = = =
10-3-11: Canaccord Reits. BUY on Heartware (PT=101); Positive HVAD Data at EACTS
. . . http://investorshub.advfn.com/boards/read_msg.aspx?message_id=67622843
10-3-11: Wedbush Reits. OUTPERFORM on Heartware (PT=105), based on EACTS’11 HVAD Data Update, “groundbreaking nature of HeartWare's HVAD”, the “enthusiastic response from surgeons”…
. . . http://investorshub.advfn.com/boards/read_msg.aspx?message_id=67630244
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM